Skip to content
Home/Companies/MedTech/SimSen Diagnostics

SimSen Diagnostics

MedTech·Sweden·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns SimSen Diagnostics?

SimSen Diagnostics is a Swedish MedTech company, currently owned by GU Ventures since 2020.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorMedTech
StatusActive

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Mucolife Therapeutics
Active
BiotechSweden· 2024
Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
Hydroc Energy Storage
Active
ClimateTechSweden· 2019
Sobrera Pharma
Active
PharmaSweden· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns SimSen Diagnostics?

SimSen Diagnostics is currently owned by GU Ventures, through GU Ventures Evergreen, since 2020.

When did GU Ventures acquire SimSen Diagnostics?

GU Ventures acquired SimSen Diagnostics in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue